Xiaoqing Yu

15PUBLICATIONS
175CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyMedical molecular engineering of nucleic acids and proteinsBiomedical imagingPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 25, 2026
Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial.

|May 21, 2026
A MAFG~MITF complex drives melanoma phenotype switching and progression.

|Feb 11, 2026
Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents.

Dimitrios Drekolias, Fatima Tuz Zahra, Caroline Fileni

|Feb 09, 2026
A Multi-Step Immune-Competent Genetically Engineered Mouse Model Reveals Phenotypic Plasticity in Uveal Melanoma.

Xiaonan Xu, Xiaoxian Liu, Vinesh Jarajapu

|Jan 13, 2026
CGPA: A Multicontext Cancer Gene Prognosis Atlas.

Biwei Cao, Xiaoqing Yu, Guillermo Gonzalez

|Dec 12, 2025
TAp73 mediates anti-tumor immunity through regulation of lipid metabolism in the lung tumor microenvironment.

Hayley D Ackerman, Vanessa Y Rubio, Andrew J Davis

Pageof 3

Frequent Collaborators

4 joint publications

Kenneth Y Tsai

3 joint publications

Paulo C Rodriguez

3 joint publications

Steven Eschrich

3 joint publications

Xiaonan Xu